FINILAC 50 MICROGRAM/ML ORAL SOLUTION FOR DOGS AND CATS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
25-07-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CABERGOLINE
Available from:
Le Vet Beheer B.V.
ATC code:
QG02CB03
INN (International Name):
CABERGOLINE
Dosage:
50 Microgram/ML
Pharmaceutical form:
Oral Solution
Prescription type:
POM
Therapeutic group:
Canine, Feline
Therapeutic area:
Cabergoline
Therapeutic indications:
Hormone
Authorization status:
Authorised
Authorization date:
2015-07-10
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Finilac 50 microgram/ml oral solution for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCE:
Cabergoline 50 microgram
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral solution.
A clear, colourless to slightly brownish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog, Cat
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of false pregnancy in bitches.
Suppression of lactation in bitches and queens.
4.3 CONTRAINDICATIONS
Do not use in pregnant animals since the product may cause abortion.
Do not use with dopamine antagonists.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Additional supportive treatments should involve restriction of water and carbohydrate intake and increased exercise.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 10/07/2015_
_CRN 7017266_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash hands after use.
Avoid contact with skin and eyes. Wash off any splashes immediately.
Women of childbearing potential and breast-feeding woman should not handle the product or should wear impervious
gloves when administering the product.
If you know you are hypersensitive to cabergoline or any of the other ingredients in the product, you should avoid
contact with the product.
Do not leave unattended filled syringes in the presence of children. In the event of
Read the complete document
